These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 714830

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug dosage in renal disease.
    Dettli L.
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [Abstract] [Full Text] [Related]

  • 3. Renal failure, drug pharmacokinetics and drug action.
    Fabre J, Balant L.
    Clin Pharmacokinet; 1976; 1(2):99-120. PubMed ID: 13956
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics in renal failure.
    Nancarrow C, Mather LE.
    Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics in renal disease.
    Levy G.
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dose adjustment in patients with liver disease.
    Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S.
    Drug Saf; 2005 Apr; 28(6):529-45. PubMed ID: 15924505
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics in patients with renal failure.
    Maher JF.
    Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
    [Abstract] [Full Text] [Related]

  • 12. The influence of chronic renal failure on drug metabolism and transport.
    Dreisbach AW.
    Clin Pharmacol Ther; 2009 Nov; 86(5):553-6. PubMed ID: 19776735
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The one-point method in predicting dosage regimen in case of hepatic and/or renal failure in presence or absence of change in volume of distribution.
    Ritschel WA, Thompson GA.
    J Clin Pharmacol; 1979 Jul; 19(7):350-6. PubMed ID: 479379
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics in clinical practice. I. Concepts.
    Gibaldi M, Levy G.
    JAMA; 1976 Apr 26; 235(17):1864-7. PubMed ID: 946488
    [Abstract] [Full Text] [Related]

  • 17. Drug dosing guidelines in patients with renal failure.
    Swan SK, Bennett WM.
    West J Med; 1992 Jun 26; 156(6):633-8. PubMed ID: 1615656
    [Abstract] [Full Text] [Related]

  • 18. [Drug therapy in impaired liver and kidney function].
    Galeazzi RL.
    Schweiz Med Wochenschr; 1983 May 21; 113(20):726-32. PubMed ID: 6879125
    [Abstract] [Full Text] [Related]

  • 19. [Appropriate pharmacotherapy in patients with chronic kidney disease - new approach - ].
    Hirata S.
    Yakugaku Zasshi; 2012 May 21; 132(4):461-70. PubMed ID: 22465923
    [Abstract] [Full Text] [Related]

  • 20. Altered nonrenal drug clearance in ESRD.
    Nolin TD.
    Curr Opin Nephrol Hypertens; 2008 Nov 21; 17(6):555-9. PubMed ID: 18941346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.